Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping DR Borger, KK Tanabe, KC Fan, HU Lopez, VR Fantin, KS Straley, ... The oncologist 17 (1), 72-79, 2012 | 816 | 2012 |
Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic‐pathologic correlation SN Goldberg, GS Gazelle, CC Compton, PR Mueller, KK Tanabe Cancer: Interdisciplinary International Journal of the American Cancer …, 2000 | 787 | 2000 |
Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte–macrophage colony-stimulating factor generates potent antitumor immunity in … R Soiffer, T Lynch, M Mihm, K Jung, C Rhuda, JC Schmollinger, FS Hodi, ... Proceedings of the National Academy of Sciences 95 (22), 13141-13146, 1998 | 735 | 1998 |
Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? SN Goldberg, PF Hahn, KK Tanabe, PR Mueller, W Schima, ... Journal of Vascular and Interventional Radiology 9 (1), 101-111, 1998 | 710 | 1998 |
Minimal-access surgery for staging of malignant melanoma DN Krag, SJ Meijer, DL Weaver, BW Loggie, SP Harlow, KK Tanabe, ... Archives of Surgery 130 (6), 654-658, 1995 | 616 | 1995 |
Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic … TS Hong, JY Wo, BY Yeap, E Ben-Josef, EI McDonnell, LS Blaszkowsky, ... Journal of Clinical Oncology 34 (5), 460-468, 2016 | 449 | 2016 |
Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells BC Fuchs, T Fujii, JD Dorfman, JM Goodwin, AX Zhu, M Lanuti, ... Cancer research 68 (7), 2391-2399, 2008 | 398 | 2008 |
Expression of CD44R1 adhesion molecule in colon carcinomas and metastases KK Tanabe, LM Ellis, H Saya The Lancet 341 (8847), 725-726, 1993 | 390 | 1993 |
Cutaneous melanoma, version 2.2019, NCCN clinical practice guidelines in oncology DG Coit, JA Thompson, MR Albertini, C Barker, WE Carson, C Contreras, ... Journal of the National Comprehensive Cancer Network 17 (4), 367-402, 2019 | 389 | 2019 |
Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments … R Soiffer, FS Hodi, F Haluska, K Jung, S Gillessen, S Singer, K Tanabe, ... Journal of clinical oncology 21 (17), 3343-3350, 2003 | 386 | 2003 |
Ablation of liver tumors using percutaneous RF therapy. SN Goldberg, GS Gazelle, L Solbiati, T Livraghi, KK Tanabe, PF Hahn, ... AJR. American journal of roentgenology 170 (4), 1023-1028, 1998 | 385 | 1998 |
Prognosis and survival in patients with gastrointestinal tract carcinoid tumors KO Shebani, WW Souba, DM Finkelstein, PC Stark, KM Elgadi, ... Annals of surgery 229 (6), 815, 1999 | 367 | 1999 |
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma BC Fuchs, Y Hoshida, T Fujii, L Wei, S Yamada, GY Lauwers, CM McGinn, ... Hepatology 59 (4), 1577-1590, 2014 | 351 | 2014 |
Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin‐associated liver lesions and partially prevented by bevacizumab in patients with … L Rubbia‐Brandt, GY Lauwers, H Wang, PE Majno, K Tanabe, A X Zhu, ... Histopathology 56 (4), 430-439, 2010 | 351 | 2010 |
Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma DJ Erstad, KK Tanabe Annals of surgical oncology 26, 1474-1493, 2019 | 342 | 2019 |
Surgical management of phyllodes tumors AA Mangi, BL Smith, MA Gadd, KK Tanabe, MJ Ott, WW Souba Archives of Surgery 134 (5), 487-493, 1999 | 334 | 1999 |
Influence of surgical margins on outcome in patients with preoperatively irradiated extremity soft tissue sarcomas KK Tanabe, RE Pollock, LM Ellis, A Murphy, N Sherman, MM Romsdahl Cancer 73 (6), 1652-1659, 1994 | 312 | 1994 |
TAS-120 overcomes resistance to ATP-competitive FGFR inhibitors in patients with FGFR2 fusion–positive intrahepatic cholangiocarcinoma L Goyal, L Shi, LY Liu, F Fece de la Cruz, JK Lennerz, S Raghavan, ... Cancer discovery 9 (8), 1064-1079, 2019 | 292 | 2019 |
Inhibition of acetyl-CoA carboxylase by phosphorylation or the inhibitor ND-654 suppresses lipogenesis and hepatocellular carcinoma JSV Lally, S Ghoshal, DK DePeralta, O Moaven, L Wei, R Masia, ... Cell metabolism 29 (1), 174-182. e5, 2019 | 280 | 2019 |
Morbidity and mortality after liver resection: results of the patient safety in surgery study S Virani, JS Michaelson, MM Hutter, RT Lancaster, AL Warshaw, ... Journal of the American College of Surgeons 204 (6), 1284-1292, 2007 | 272 | 2007 |